Risk factors for abandonment of Wilms tumor therapy in Kenya. Issue 2 (8th November 2014)
- Record Type:
- Journal Article
- Title:
- Risk factors for abandonment of Wilms tumor therapy in Kenya. Issue 2 (8th November 2014)
- Main Title:
- Risk factors for abandonment of Wilms tumor therapy in Kenya
- Authors:
- Libes, Jaime
Oruko, Oliver
Abdallah, Fatmah
Githanga, Jessie
Ndung'u, James
Musimbi, Joyce
Njuguna, Festus
Patel, Kirtika
White, John
Axt, Jason R.
O'Neill, James A.
Shrubsole, Martha
Li, Ming
Lovvorn, Harold N. - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pbc25312-sec-0001" sec-type="section"> <title>Background</title> <p>Survival from Wilms tumor (WT) in sub‐Saharan Africa remains dismal as a result of on‐therapy mortality and treatment abandonment. Review of patients diagnosed from 2008 to 2011 in our Kenyan Wilms Tumor Registry showed a loss to follow up (LTFU) rate approaching 50%. The purpose of this study was to trace those LTFU, estimate the survival rate, and identify risk factors for treatment abandonment.</p> </sec> <sec id="pbc25312-sec-0002" sec-type="section"> <title>Procedure</title> <p>We administered a comprehensive survey to parents of patients with WT at the two largest referral hospitals in Kenya to identify barriers to care. We also telephoned families who had abandoned care to determine vital status and identify risk factors for treatment abandonment.</p> </sec> <sec id="pbc25312-sec-0003" sec-type="section"> <title>Results</title> <p>Of 136 registered patients, 77 were confirmed dead (56.7%), 38 remained alive (27.9%), and the vital status of 21 patients remains unknown (15.4%). After contacting 33 of the patients who either abandoned curative treatment (n = 34) or did not attend off‐therapy visits (n = 20), the best estimate of 2‐year overall survival of patients with WT in Kenya approaches 36%. Sixty‐three percent of parents misunderstood treatment plans and 55% encountered financial barriers.<abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="pbc25312-sec-0001" sec-type="section"> <title>Background</title> <p>Survival from Wilms tumor (WT) in sub‐Saharan Africa remains dismal as a result of on‐therapy mortality and treatment abandonment. Review of patients diagnosed from 2008 to 2011 in our Kenyan Wilms Tumor Registry showed a loss to follow up (LTFU) rate approaching 50%. The purpose of this study was to trace those LTFU, estimate the survival rate, and identify risk factors for treatment abandonment.</p> </sec> <sec id="pbc25312-sec-0002" sec-type="section"> <title>Procedure</title> <p>We administered a comprehensive survey to parents of patients with WT at the two largest referral hospitals in Kenya to identify barriers to care. We also telephoned families who had abandoned care to determine vital status and identify risk factors for treatment abandonment.</p> </sec> <sec id="pbc25312-sec-0003" sec-type="section"> <title>Results</title> <p>Of 136 registered patients, 77 were confirmed dead (56.7%), 38 remained alive (27.9%), and the vital status of 21 patients remains unknown (15.4%). After contacting 33 of the patients who either abandoned curative treatment (n = 34) or did not attend off‐therapy visits (n = 20), the best estimate of 2‐year overall survival of patients with WT in Kenya approaches 36%. Sixty‐three percent of parents misunderstood treatment plans and 55% encountered financial barriers. When asked how to increase comfort with the child's treatment, 27% of parents volunteered improving inefficient services and 26% volunteered reducing drug‐unavailability.</p> </sec> <sec id="pbc25312-sec-0004" sec-type="section"> <title>Conclusions</title> <p>Treatment abandonment remains a significant problem contributing to increased mortality from WT in developing countries. This multi‐center survey identified the barriers to treatment completion from the parental perspective to be lack of education about WT and treatment, financial constraints, need for quality improvement, and drug‐unavailability. Pediatr Blood Cancer 2015;62:252–256. © 2014 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- Pediatric blood & cancer. Volume 62:Issue 2(2015:Feb.)
- Journal:
- Pediatric blood & cancer
- Issue:
- Volume 62:Issue 2(2015:Feb.)
- Issue Display:
- Volume 62, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 62
- Issue:
- 2
- Issue Sort Value:
- 2015-0062-0002-0000
- Page Start:
- 252
- Page End:
- 256
- Publication Date:
- 2014-11-08
- Subjects:
- Tumors in children -- Periodicals
Blood -- Diseases -- Periodicals
Cancer in children -- Periodicals
618.92 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1545-5017 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/pbc.25312 ↗
- Languages:
- English
- ISSNs:
- 1545-5009
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6417.533500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3689.xml